银华中证港股通医药卫生综合ETF(159776)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
45,458,016.71 |
-57,093,127.14 |
-67,344,583.76 |
-41,914,505.22 |
| 利息合计 |
18,706.84 |
57,944.91 |
34,110.80 |
65,047.29 |
| 其中:存款利息收入 |
18,706.84 |
57,944.91 |
34,110.80 |
65,047.29 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
5,930,965.67 |
-56,780,525.67 |
-41,640,316.91 |
-6,337,808.79 |
| 其中:股票投资收益 |
5,470,690.81 |
-59,060,207.40 |
-42,448,953.29 |
-7,304,513.53 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
460,274.86 |
2,279,681.73 |
808,636.38 |
966,704.74 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
39,852,920.16 |
-40,581.01 |
-24,595,949.38 |
-36,191,829.25 |
| 其他收入 |
-344,575.96 |
-329,965.37 |
-1,142,428.27 |
550,085.53 |
| 费用 |
535,731.66 |
1,262,839.52 |
727,216.89 |
1,331,287.70 |
| 管理人报酬 |
306,581.03 |
767,301.65 |
450,142.87 |
799,275.88 |
| 基金托管费 |
61,316.19 |
153,460.37 |
90,028.58 |
159,855.28 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
167,834.44 |
342,077.50 |
187,045.44 |
372,156.54 |
| 利润总额 |
44,922,285.05 |
-58,355,966.66 |
-68,071,800.65 |
-43,245,792.92 |